Zimbabwe has turned down a major US health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's request for sensitive biological samples.
This move became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative has since clarified that the US was requesting genetic material for scientific study and commercial gain but was unwilling to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for continued talks to find a deal suitable to both sides so the country's vital HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were raised about the security of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on reports, Sixteen African countries have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population should a new disease outbreak arise."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting structures already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with future pandemics.
"This system is intended to guarantee that when a nation provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future co-operation might be structured in a way that honours the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that negotiations need to persist given that a large portion of the nation's HIV programmes were funded by external financing.
"If technical issues exist, such as those relating to data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it said.
This impasse emphasises the continuing challenges between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.